T9	Exp 178 189	The cascade
T10	Exp 207 228	the first few minutes
T11	Exp 411 433	the rate-limiting step
T12	Exp 569 571	we
T13	Exp 610 623	their ability
T14	Exp 818 825	its own
T15	Exp 595 599	that
T16	Exp 661 666	which
T17	Exp 777 782	which
T18	Exp 827 829	We
T19	Exp 836 840	that
T20	Exp 882 891	both mAbs
T21	Exp 925 956	the inositol phosphate response
T22	Exp 1034 1036	we
T23	Exp 1079 1090	the nucleus
T24	Exp 1001 1013	these events
T25	Exp 1140 1154	the appearance
T26	Exp 1158 1170	the NF-kappa
T27	Exp 1266 1277	the nucleus
T28	Exp 1119 1131	Both stimuli
T29	Exp 1345 1356	its ability
T30	Exp 1315 1326	the nucleus
T31	Exp 1440 1450	the levels
T32	Exp 1558 1570	the response
T33	Exp 1575 1589	the other hand
T34	Exp 1660 1697	the smaller second messenger response
R6	Coref Anaphora:T15 Antecedent:T35
R7	Coref Anaphora:T13 Antecedent:T35
R8	Coref Anaphora:T16 Antecedent:T36
R9	Coref Anaphora:T14 Antecedent:T37
R10	Coref Anaphora:T29 Antecedent:T38
T1	Protein 88 92	IL-2
T2	Protein 1185 1190	c-Rel
T3	Protein 1192 1195	p65
T4	Protein 1197 1201	RelA
T5	Protein 1208 1211	p50
T6	Protein 1213 1224	NF-kappa B1
T7	Protein 1404 1408	IL-2
T35	Exp 577 594	two anti-CD3 mAbs
T36	Exp 655 659	OKT3
T37	Exp 794 814	T cell proliferation
T38	Exp 1306 1311	NF-AT
